![]() |
市場調查報告書
商品編碼
1636721
2030 年氰乙酸乙酯市場預測:按等級、功能、應用和地區進行的全球分析Ethyl Cyanoacetate Market Forecasts to 2030 - Global Analysis By Grade (Pharmaceutical Grade and Industrial Grade), Function (Chemical Intermediates, Polymerization Agents and Catalysts), Application and By Geography |
根據 Stratistics MRC 的數據,2024 年全球氰乙酸乙酯市值為 1.459 億美元,預計到 2030 年將達到 2.023 億美元,預測期內的複合年成長率為 5.6%。
氰乙酸乙酯是一種用途廣泛的有機化合物,分子式為 C5H7NO2,含有氰基(-CN)和酯基(-COOEt)。它是一種無色黃色液體,具有水果、食用氣味,作為生物製藥中間體發揮重要作用。氰乙酸乙酯在醫藥、農業化學品和合成化學品中發揮重要作用,並因其在縮合和聚合反應中的活性而受到重視。
根據1975年至1989年的生產資料,美國氰基丙烯酸酯膠黏劑的工業消費量增加了500%。
藥品需求不斷成長
氰乙酸乙酯作為藥物合成的關鍵中間體的用途日益廣泛,推動了市場的成長。氰乙酸乙酯在抗癌藥、抗發炎藥、抗病毒藥物等藥物研發中扮演重要角色。慢性病發病率的上升和製藥業的蓬勃發展(尤其是在新興國家)正在推動需求。此外,化學合成技術的進步提高了生產效率,使得氰乙酸乙酯在藥物應用上不可或缺。
原物料價格波動
原物料價格波動對氰乙酸乙酯市場構成重大挑戰。乙醇和氰乙酸等基本投入品成本的波動會影響生產成本,並為製造商帶來定價不確定性。這種波動會影響利潤率並阻礙長期投資。此外,儘管需求不斷成長,但替代化學品的競爭增加了價格壓力並限制了市場擴張。
個性化醫療的發展
個人化醫療的興起為氰乙酸乙酯市場提供了重大機會。隨著製藥公司專注於開發個人化治療方法,對氰乙酸乙酯等特殊中間體的需求正在增加。氰乙酸乙酯在複雜有機化合物的合成上用途廣泛,是製造小眾藥物的必需原料。這一趨勢與生物技術和精準醫療的進步相吻合,為製造商創造了豐厚的成長前景。
健康和安全風險
使用氰乙酸乙酯所帶來的健康和安全風險對市場成長構成了突出威脅。由於其毒性,需要嚴格的處理和儲存通訊協定,以防止與接觸相關的風險。此外,遵守環境和職業安全標準也增加了營運的複雜性。如果不解決這些風險,可能會導致法律處罰、聲譽損害和失去客戶信任。
新冠疫情擾亂了全球供應鏈,暫時減緩了氰乙酸乙酯的生產。然而,疫情期間人們對藥品製造的關注度增加,也增加了對其作為藥物合成關鍵中間體的需求。預計醫療保健和農業領域的疫情後復甦努力將維持市場的長期成長。
預計預測期內製藥和醫療保健將成為最大的細分市場。
由於氰乙酸乙酯在藥物合成中的廣泛應用,預計預測期內製藥和醫療保健領域將佔據最大的市場佔有率。氰乙酸乙酯是一種用途廣泛的中間體,是製造多種藥物(包括抗癌藥物和抗病毒藥物)的必需原料。全球對創新治療的需求不斷成長,進一步推動了該領域的應用。
預計預測期內工業級部分將以最高的複合年成長率成長。
由於農業化學品、黏合劑和特殊化學品的應用不斷增加,工業級部分預計將在預測期內見證最高的複合年成長率。工業級氰乙酸乙酯為大規模生產過程提供了經濟高效的解決方案。各行業對高性能材料的需求不斷成長,推動了該等級材料的需求並推動了快速成長。
由於亞太地區擁有強大的工業基礎設施以及不斷擴大的製藥和農業化學品行業,預計在預測期內將佔據最大的市場佔有率。中國和印度等國家憑藉其成本效益高的製造能力和對特種化學品的高需求,在生產和消費方面處於領先地位。該地區強勁的經濟成長將進一步推動市場擴張。
由於積極的研發投資以及醫藥和農業化學品領域的技術進步,預計北美地區在預測期內將實現最高成長率。該地區對永續農業和高品質藥品生產的重視正在推動對氰乙酸乙酯作為關鍵中間體的需求。良好的法律規範進一步增強了成長前景。
According to Stratistics MRC, the Global Ethyl Cyanoacetate Market is accounted for $145.9 million in 2024 and is expected to reach $202.3 million by 2030 growing at a CAGR of 5.6% during the forecast period. Ethyl cyanoacetate is a versatile organic compound with the formula C5H7NO2, characterized by a cyano group (-CN) and an ester group (-COOEt). It is a colorless yellow liquid with a fruity, edible odor, playing an important role as an intermediate in the production of biological products. Ethyl cyanoacetate plays an important role in pharmaceuticals, agricultural chemicals, and synthetics and is valued for its activity in condensation and polymerization reactions.
According to production data between 1975-1989, US industrial consumption of cyanoacrylate adhesives increased 500%.
Growing demand in pharmaceuticals
The increasing use of ethyl cyanoacetate as a key intermediate in pharmaceutical synthesis drives market growth. It plays a crucial role in developing drugs like anti-cancer, anti-inflammatory, and antiviral agents. The rising prevalence of chronic diseases and the growing pharmaceutical industry, especially in emerging economies, are boosting demand. Additionally, advancements in chemical synthesis technologies enhance production efficiency, making ethyl cyanoacetate indispensable for pharmaceutical applications.
Fluctuating raw material prices
Fluctuating raw material prices pose a significant challenge to the ethyl cyanoacetate market. Variability in the cost of essential inputs like ethanol and cyanoacetic acid impacts production costs, creating pricing uncertainties for manufacturers. This volatility affects profit margins and discourages long-term investments. Moreover, competition from alternative chemicals further intensifies pricing pressures, limiting market expansion despite growing demand.
Growth in personalized medicine
The rise of personalized medicine offers significant opportunities for the ethyl cyanoacetate market. As pharmaceutical companies focus on developing tailored treatments, the demand for specialized intermediates like ethyl cyanoacetate is increasing. Its versatility in synthesizing complex organic compounds makes it vital for producing niche drugs. This trend aligns with advancements in biotechnology and precision medicine, creating lucrative growth prospects for manufacturers.
Health and safety risks
Health and safety risks associated with ethyl cyanoacetate usage present a notable threat to market growth. Its toxic nature requires stringent handling and storage protocols to prevent exposure-related hazards. Regulatory compliance with environmental and occupational safety standards adds to operational complexities. Failure to address these risks can result in legal penalties, reputational damage, and loss of customer trust.
The COVID-19 pandemic disrupted global supply chains, temporarily slowing ethyl cyanoacetate production. However, the increased focus on pharmaceutical manufacturing during the pandemic boosted its demand as a key intermediate for drug synthesis. Post-pandemic recovery efforts in healthcare and agriculture are expected to sustain long-term growth for the market.
The pharmaceutical & healthcare segment is expected to be the largest during the forecast period
The pharmaceutical & healthcare segment is expected to account for the largest market share during the forecast period due to its extensive use of ethyl cyanoacetate in drug synthesis. Its role as a versatile intermediate makes it indispensable for producing a wide range of pharmaceuticals, including anti-cancer and antiviral drugs. The growing global demand for innovative treatments further drives adoption in this segment.
The industrial grade segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the industrial grade segment is expected to witness the highest CAGR due to its increasing application in agrochemicals, adhesives, and specialty chemicals. Industrial-grade ethyl cyanoacetate offers cost-effective solutions for large-scale production processes. The rising need for high-performance materials across industries boosts demand for this grade, driving its rapid growth.
The Asia Pacific region is anticipated to account for the largest market share during the forecast period due to its robust industrial infrastructure and expanding pharmaceutical and agrochemical sectors. Countries like China and India lead production and consumption due to their cost-efficient manufacturing capabilities and high demand for specialty chemicals. The region's dynamic economic growth further supports market expansion.
The North America region is anticipated to register the highest growth rate over the forecast period owing to its strong R&D investments and technological advancements in pharmaceuticals and agrochemicals. The region's focus on sustainable farming practices and high-quality drug production drives demand for ethyl cyanoacetate as a critical intermediate. Favorable regulatory frameworks further enhance growth prospects.
Key players in the market
Some of the key players in Ethyl Cyanoacetate Market include Merck KGaA, Shandong Xinhua Pharmaceutical Co., Ltd., Tiande Chemical Holdings Limited, Tokyo Chemical Industry Co., Ltd., HeBei ChengXin, TATEYAMA KASEI Co., Ltd., Triveni Chemicals, EMCO Dyestuff Pvt Ltd, Loba Chemie Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., CDH Fine Chemical, VIVAN Life Sciences, Alfa Chemistry, BOC Sciences, Luxembourg Bio Technologies, Frinton Laboratories, US Biological Life Sciences and VWR International.
In December 2024, Merck, a leading science and technology company announced that it will invest over €70 million to construct a new Advanced Materials Development Center (AMDC) at its Shizuoka site in Japan. This latest investment brings Merck's total investment in the Shizuoka site to over €120 million since 2021, enhancing its existing capabilities in advanced patterning and underscoring the company's dedication to advancing semiconductor technology, expanding research and development capacities, and supporting the growth of the global electronics industry.
In December 2023, BOC Sciences and Spaya have joined forces to expand their chemical offerings, enhancing product diversity and manufacturing capabilities. By joining forces, the two companies create a powerful synergy that exponentially augments the scope and diversity of chemical products available to scientists.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.